Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kempharm Inc (NQ: KMPH ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 28, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 5.690 (8) Ask (Size) 6.000 (20) Prev. Close 5.810 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 33,932,639 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CORRECTION – KemPharm Announces Corporate Name Change to Zevra Therapeutics February 22, 2023 From KemPharm Via GlobeNewswire KemPharm Announces Corporate Name Change to Zevra Therapeutics February 22, 2023 From KemPharm Via GlobeNewswire Performance More News Read More This Rare Disease Focused Stock Pipeline Is Underappreciated, Analyst Initiating Coverage Says November 17, 2022 Via Benzinga KemPharm's Earnings: A Preview November 08, 2022 Via Benzinga KemPharm's Lead Prodrug Shows Favorable Safety Profile For Rare Sleeping Disorder September 28, 2022 Via Benzinga Recap: KemPharm Q2 Earnings August 11, 2022 Via Benzinga KemPharm Acquires Battered Orphazyme's Arimoclomol Program For $13M May 16, 2022 Via Benzinga KemPharm's SDX Higher Dose Shows Potential Against Sleep Disorders March 21, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 November 17, 2022 Via Benzinga US Stocks Turn Lower; Nasdaq Drops Over 100 Points September 15, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022 September 15, 2022 Via Benzinga Apple To $220? Here Are 5 Other Price Target Changes For Wednesday August 17, 2022 Via Benzinga Recap: KemPharm Q1 Earnings May 12, 2022 Via Benzinga Earnings Preview For KemPharm May 11, 2022 Via Benzinga The Technology Helping Existing FDA-Approved Drugs Target More Effectively May 03, 2022 Via Benzinga Benzinga Announces This Week's All Access Guests April 28, 2022 Via Benzinga 26 Stocks Moving in Monday's Pre-Market Session April 25, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Thursday March 31, 2022 Via Benzinga Earnings Scheduled For March 30, 2022 March 30, 2022 Via Benzinga KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder January 20, 2022 Via Benzinga The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More March 27, 2022 Via Benzinga 38 Stocks Moving In Monday's Mid-Day Session December 20, 2021 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday February 16, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022 January 31, 2022 Via Benzinga 65 Biggest Movers From Yesterday December 21, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.